| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 21 | 2025 | 144 | 4.790 |
Why?
|
| Electronic Nicotine Delivery Systems | 14 | 2025 | 58 | 3.920 |
Why?
|
| Nicotinic Agonists | 7 | 2025 | 38 | 1.940 |
Why?
|
| Vaping | 5 | 2025 | 26 | 1.720 |
Why?
|
| Receptors, Nicotinic | 5 | 2020 | 10 | 1.540 |
Why?
|
| Animals | 39 | 2026 | 1875 | 1.520 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 16 | 1.170 |
Why?
|
| Aerosols | 6 | 2025 | 15 | 1.170 |
Why?
|
| Respiratory Center | 7 | 2020 | 8 | 1.020 |
Why?
|
| Tobacco Products | 2 | 2025 | 14 | 0.850 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2024 | 282 | 0.780 |
Why?
|
| Mice, Inbred C57BL | 16 | 2026 | 258 | 0.770 |
Why?
|
| Seizures | 2 | 2020 | 16 | 0.770 |
Why?
|
| Behavior, Animal | 2 | 2020 | 30 | 0.770 |
Why?
|
| Mice | 18 | 2026 | 746 | 0.750 |
Why?
|
| Respiration | 3 | 2019 | 13 | 0.730 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2024 | 93 | 0.700 |
Why?
|
| Rats | 16 | 2024 | 571 | 0.700 |
Why?
|
| Male | 23 | 2025 | 3671 | 0.670 |
Why?
|
| Receptors, GABA-A | 5 | 2020 | 6 | 0.660 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 9 | 0.630 |
Why?
|
| Reperfusion Injury | 2 | 2020 | 7 | 0.620 |
Why?
|
| Drug Delivery Systems | 3 | 2018 | 12 | 0.600 |
Why?
|
| Atherosclerosis | 3 | 2026 | 39 | 0.600 |
Why?
|
| Pregnancy | 11 | 2024 | 599 | 0.590 |
Why?
|
| Altitude Sickness | 1 | 2018 | 2 | 0.580 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 11 | 0.580 |
Why?
|
| Heart Diseases | 1 | 2018 | 9 | 0.570 |
Why?
|
| Uterus | 1 | 2017 | 15 | 0.540 |
Why?
|
| Diet, High-Fat | 3 | 2025 | 59 | 0.540 |
Why?
|
| Disease Models, Animal | 9 | 2026 | 231 | 0.540 |
Why?
|
| Cigarette Smoking | 1 | 2017 | 20 | 0.530 |
Why?
|
| Flavonols | 5 | 2022 | 5 | 0.530 |
Why?
|
| Cotinine | 4 | 2020 | 21 | 0.480 |
Why?
|
| Smoking | 4 | 2020 | 86 | 0.440 |
Why?
|
| Female | 14 | 2026 | 4060 | 0.440 |
Why?
|
| Patch-Clamp Techniques | 4 | 2013 | 5 | 0.440 |
Why?
|
| DNA Methylation | 3 | 2024 | 26 | 0.430 |
Why?
|
| Neurons | 4 | 2012 | 50 | 0.410 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 9 | 0.390 |
Why?
|
| Hypertension | 2 | 2025 | 147 | 0.390 |
Why?
|
| Respiratory Mechanics | 2 | 2003 | 6 | 0.390 |
Why?
|
| Diet, Western | 2 | 2025 | 8 | 0.380 |
Why?
|
| Brain | 2 | 2024 | 94 | 0.380 |
Why?
|
| Animals, Newborn | 5 | 2024 | 112 | 0.380 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2020 | 34 | 0.380 |
Why?
|
| Autophagy | 3 | 2021 | 29 | 0.370 |
Why?
|
| Heart | 3 | 2020 | 25 | 0.360 |
Why?
|
| Medulla Oblongata | 2 | 2020 | 3 | 0.360 |
Why?
|
| Humans | 14 | 2023 | 6794 | 0.350 |
Why?
|
| Protein Subunits | 3 | 2017 | 7 | 0.340 |
Why?
|
| Arenaria Plant | 2 | 2020 | 2 | 0.310 |
Why?
|
| Flavonoids | 2 | 2020 | 6 | 0.310 |
Why?
|
| CpG Islands | 3 | 2024 | 4 | 0.310 |
Why?
|
| Signal Transduction | 4 | 2024 | 246 | 0.300 |
Why?
|
| Ion Transport | 2 | 2019 | 2 | 0.280 |
Why?
|
| Anion Transport Proteins | 2 | 2019 | 2 | 0.280 |
Why?
|
| Antiporters | 2 | 2019 | 4 | 0.280 |
Why?
|
| Blood Pressure | 2 | 2025 | 112 | 0.270 |
Why?
|
| Maternal Exposure | 3 | 2024 | 17 | 0.260 |
Why?
|
| Neurochemistry | 1 | 2006 | 1 | 0.250 |
Why?
|
| Biological Assay | 1 | 2006 | 4 | 0.250 |
Why?
|
| Central Nervous System | 1 | 2006 | 8 | 0.250 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 5 | 0.250 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 18 | 0.250 |
Why?
|
| Nicotinic Antagonists | 3 | 2017 | 4 | 0.250 |
Why?
|
| Transcriptome | 2 | 2024 | 31 | 0.250 |
Why?
|
| Electrodes | 1 | 2006 | 2 | 0.250 |
Why?
|
| Physical Conditioning, Animal | 1 | 2026 | 1 | 0.250 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2026 | 9 | 0.240 |
Why?
|
| Ventricular Remodeling | 1 | 2026 | 5 | 0.240 |
Why?
|
| Calcinosis | 1 | 2026 | 12 | 0.240 |
Why?
|
| Vascular Calcification | 1 | 2026 | 12 | 0.240 |
Why?
|
| Sodium-Bicarbonate Symporters | 2 | 2018 | 2 | 0.240 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 3 | 0.240 |
Why?
|
| Hyperlipidemias | 1 | 2025 | 22 | 0.230 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2025 | 5 | 0.230 |
Why?
|
| Social Isolation | 2 | 2022 | 10 | 0.230 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 75 | 0.220 |
Why?
|
| Ethanol | 2 | 2017 | 86 | 0.220 |
Why?
|
| Myocardial Ischemia | 2 | 2024 | 9 | 0.220 |
Why?
|
| Receptors, Angiotensin | 1 | 2024 | 4 | 0.220 |
Why?
|
| Ventricular Function, Left | 2 | 2025 | 21 | 0.210 |
Why?
|
| Myocardium | 2 | 2020 | 25 | 0.200 |
Why?
|
| Hippocampus | 3 | 2022 | 19 | 0.200 |
Why?
|
| Plant Extracts | 2 | 2020 | 10 | 0.200 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 23 | 0.200 |
Why?
|
| Kidney | 1 | 2025 | 184 | 0.200 |
Why?
|
| Sodium | 3 | 2019 | 43 | 0.200 |
Why?
|
| Obesity | 1 | 2025 | 226 | 0.200 |
Why?
|
| Inhalation | 1 | 2003 | 1 | 0.200 |
Why?
|
| Receptors, AMPA | 1 | 2003 | 3 | 0.200 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 8 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2026 | 59 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 13 | 0.190 |
Why?
|
| Oxidative Stress | 5 | 2020 | 102 | 0.190 |
Why?
|
| Astrocytes | 1 | 2022 | 9 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2019 | 150 | 0.180 |
Why?
|
| Microglia | 1 | 2022 | 5 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 15 | 0.180 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 45 | 0.180 |
Why?
|
| Membrane Potentials | 4 | 2013 | 14 | 0.180 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 3 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2022 | 30 | 0.180 |
Why?
|
| Biological Clocks | 2 | 2019 | 5 | 0.180 |
Why?
|
| Anxiety | 3 | 2022 | 35 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 36 | 0.170 |
Why?
|
| Geraniaceae | 1 | 2020 | 1 | 0.170 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 3 | 0.170 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2008 | 5 | 0.170 |
Why?
|
| Mice, Obese | 1 | 2020 | 16 | 0.170 |
Why?
|
| Buffers | 1 | 2020 | 2 | 0.160 |
Why?
|
| HEK293 Cells | 5 | 2020 | 16 | 0.160 |
Why?
|
| Amygdala | 1 | 2020 | 1 | 0.160 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2020 | 1 | 0.160 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2020 | 7 | 0.160 |
Why?
|
| Adenine | 1 | 2020 | 4 | 0.160 |
Why?
|
| Ammonia | 1 | 2019 | 1 | 0.160 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 6 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2020 | 54 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 25 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 58 | 0.150 |
Why?
|
| Apoptosis | 1 | 2020 | 179 | 0.150 |
Why?
|
| Stroke Volume | 1 | 2019 | 20 | 0.150 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2018 | 1 | 0.150 |
Why?
|
| Asteraceae | 1 | 2018 | 1 | 0.140 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2018 | 1 | 0.140 |
Why?
|
| Fetal Heart | 1 | 2018 | 3 | 0.140 |
Why?
|
| Altitude | 1 | 2018 | 3 | 0.140 |
Why?
|
| Models, Animal | 1 | 2018 | 23 | 0.140 |
Why?
|
| Anticonvulsants | 1 | 2018 | 9 | 0.140 |
Why?
|
| Hypoxia | 1 | 2018 | 37 | 0.140 |
Why?
|
| Fatty Liver | 1 | 2019 | 59 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 58 | 0.140 |
Why?
|
| Acids | 1 | 2018 | 1 | 0.140 |
Why?
|
| Alkalies | 1 | 2018 | 1 | 0.140 |
Why?
|
| Mecamylamine | 1 | 2017 | 8 | 0.140 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 17 | 0.140 |
Why?
|
| Ovary | 1 | 2017 | 19 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2017 | 94 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2016 | 40 | 0.120 |
Why?
|
| Phenotype | 3 | 2023 | 91 | 0.110 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 1 | 0.110 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 2 | 0.110 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2014 | 1 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2014 | 6 | 0.110 |
Why?
|
| Synaptic Potentials | 1 | 2014 | 2 | 0.110 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 9 | 0.110 |
Why?
|
| Alcoholism | 1 | 2014 | 25 | 0.100 |
Why?
|
| Synaptic Transmission | 2 | 2019 | 4 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 30 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2025 | 28 | 0.100 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2013 | 1 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 3 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2013 | 17 | 0.100 |
Why?
|
| Lethal Dose 50 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Equipment Design | 1 | 2012 | 20 | 0.100 |
Why?
|
| Mice, Knockout, ApoE | 2 | 2025 | 10 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2025 | 29 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2012 | 33 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2012 | 8 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2024 | 55 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 155 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 1 | 0.090 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 10 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 1 | 0.090 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2012 | 1 | 0.090 |
Why?
|
| Alcoholic Intoxication | 1 | 2012 | 3 | 0.090 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 5 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 120 | 0.090 |
Why?
|
| Bicarbonates | 3 | 2019 | 16 | 0.090 |
Why?
|
| Periodicity | 2 | 2008 | 8 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 45 | 0.090 |
Why?
|
| Inhalation Exposure | 2 | 2021 | 9 | 0.080 |
Why?
|
| Echocardiography | 2 | 2020 | 15 | 0.080 |
Why?
|
| Medicine, Tibetan Traditional | 2 | 2020 | 2 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2020 | 8 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 3 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2009 | 5 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2009 | 5 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2009 | 199 | 0.070 |
Why?
|
| Receptors, Neuropeptide | 1 | 2008 | 1 | 0.070 |
Why?
|
| Apnea | 1 | 2008 | 3 | 0.070 |
Why?
|
| Somatostatin | 1 | 2008 | 10 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 9 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 18 | 0.070 |
Why?
|
| Cell Line | 2 | 2019 | 124 | 0.070 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2008 | 1 | 0.070 |
Why?
|
| Xenopus laevis | 1 | 2008 | 5 | 0.070 |
Why?
|
| Oocytes | 1 | 2008 | 9 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 72 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 27 | 0.070 |
Why?
|
| Mutation | 2 | 2019 | 97 | 0.070 |
Why?
|
| Neurophysiology | 1 | 2006 | 1 | 0.060 |
Why?
|
| Brain Stem | 1 | 2006 | 3 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2006 | 4 | 0.060 |
Why?
|
| Microelectrodes | 1 | 2006 | 3 | 0.060 |
Why?
|
| Syringes | 1 | 2006 | 4 | 0.060 |
Why?
|
| Action Potentials | 1 | 2006 | 6 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2006 | 16 | 0.060 |
Why?
|
| Agar | 1 | 2006 | 1 | 0.060 |
Why?
|
| Diffusion | 1 | 2006 | 1 | 0.060 |
Why?
|
| Electric Capacitance | 1 | 2006 | 1 | 0.060 |
Why?
|
| Potassium Chloride | 1 | 2006 | 5 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 6 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2006 | 6 | 0.060 |
Why?
|
| Chlorides | 1 | 2006 | 12 | 0.060 |
Why?
|
| Nanotechnology | 1 | 2006 | 4 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2006 | 26 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 8 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 9 | 0.060 |
Why?
|
| Receptors, LDL | 1 | 2026 | 6 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 20 | 0.060 |
Why?
|
| Algorithms | 1 | 2006 | 83 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2006 | 53 | 0.060 |
Why?
|
| Calcium | 1 | 2006 | 117 | 0.060 |
Why?
|
| Energy Intake | 1 | 2025 | 30 | 0.060 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2025 | 5 | 0.060 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2025 | 7 | 0.060 |
Why?
|
| Sex Factors | 1 | 2025 | 155 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 27 | 0.050 |
Why?
|
| Biomarkers | 2 | 2020 | 214 | 0.050 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2023 | 1 | 0.050 |
Why?
|
| Superoxides | 1 | 2023 | 4 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2023 | 14 | 0.050 |
Why?
|
| Lipolysis | 1 | 2023 | 13 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2023 | 17 | 0.050 |
Why?
|
| Cytokines | 1 | 2023 | 80 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 187 | 0.050 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2003 | 1 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2003 | 5 | 0.050 |
Why?
|
| Hypoglossal Nerve | 1 | 2002 | 1 | 0.050 |
Why?
|
| Age Factors | 2 | 2014 | 193 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2016 | 54 | 0.050 |
Why?
|
| Maze Learning | 1 | 2022 | 2 | 0.050 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2021 | 1 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 5 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 8 | 0.040 |
Why?
|
| Gestational Age | 1 | 2021 | 58 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 1 | 0.040 |
Why?
|
| Transfection | 2 | 2013 | 56 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 9 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 17 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 29 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 10 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 7 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 19 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 15 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2020 | 15 | 0.040 |
Why?
|
| Motor Activity | 1 | 2020 | 26 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 34 | 0.040 |
Why?
|
| Fetal Development | 1 | 2020 | 28 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 20 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 10 | 0.040 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2019 | 5 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2019 | 3 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2020 | 13 | 0.040 |
Why?
|
| Receptors, Opioid, mu | 1 | 2019 | 19 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 9 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 12 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 14 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 27 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 63 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2019 | 110 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 118 | 0.040 |
Why?
|
| Pentylenetetrazole | 1 | 2018 | 1 | 0.040 |
Why?
|
| Flunitrazepam | 1 | 2018 | 2 | 0.040 |
Why?
|
| China | 1 | 2018 | 5 | 0.040 |
Why?
|
| Ion Exchange | 1 | 2018 | 1 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2018 | 2 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2018 | 3 | 0.030 |
Why?
|
| Ions | 1 | 2018 | 3 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 6 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 22 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 331 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 767 | 0.030 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2016 | 2 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 2016 | 2 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 3 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2016 | 48 | 0.030 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2014 | 19 | 0.030 |
Why?
|
| Carbonates | 1 | 2013 | 1 | 0.020 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2013 | 1 | 0.020 |
Why?
|
| Mesylates | 1 | 2013 | 1 | 0.020 |
Why?
|
| Ethylmaleimide | 1 | 2013 | 2 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 9 | 0.020 |
Why?
|
| Nitrates | 1 | 2013 | 6 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 63 | 0.020 |
Why?
|
| Gramicidin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Equipment Reuse | 1 | 2012 | 2 | 0.020 |
Why?
|
| CHO Cells | 1 | 2012 | 7 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cost Savings | 1 | 2012 | 13 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2012 | 2 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 5 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 18 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 38 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 70 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 10 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 73 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 2108 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2008 | 1 | 0.020 |
Why?
|
| Drosophila | 1 | 2008 | 3 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2008 | 2 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Nerve Net | 1 | 2008 | 3 | 0.020 |
Why?
|
| Wakefulness | 1 | 2008 | 5 | 0.020 |
Why?
|
| Dependovirus | 1 | 2008 | 8 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 7 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 19 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2006 | 2 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 5 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 10 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 25 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 13 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 39 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 57 | 0.020 |
Why?
|